Cargando…

Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes

Long intergenic non-coding RNAs (lincRNAs) are emerging as integral components of signaling pathways in various cancer types. In neuroblastoma, only a handful of lincRNAs are known as upstream regulators or downstream effectors of oncogenes. Here, we exploit RNA sequencing data of primary neuroblast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rombaut, Dries, Chiu, Hua-Sheng, Decaesteker, Bieke, Everaert, Celine, Yigit, Nurten, Peltier, Agathe, Janoueix-Lerosey, Isabelle, Bartenhagen, Christoph, Fischer, Matthias, Roberts, Stephen, D’Haene, Nicky, De Preter, Katleen, Speleman, Frank, Denecker, Geertrui, Sumazin, Pavel, Vandesompele, Jo, Lefever, Steve, Mestdagh, Pieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451017/ https://www.ncbi.nlm.nih.gov/pubmed/30952905 http://dx.doi.org/10.1038/s41598-019-42107-y

Ejemplares similares

Author Correction: Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
por: Rombaut, Dries, et al.
Publicado: (2019)

In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
por: Vanhauwaert, Suzanne, et al.
Publicado: (2018)

Publisher Correction: In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
por: Vanhauwaert, Suzanne, et al.
Publicado: (2019)

Zipper plot: visualizing transcriptional activity of genomic regions
por: Avila Cobos, Francisco, et al.
Publicado: (2017)

SMARTer single cell total RNA sequencing
por: Verboom, Karen, et al.
Publicado: (2019)

RNA pre-amplification enables large-scale RT-qPCR gene-expression studies on limiting sample amounts
por: Vermeulen, Joëlle, et al.
Publicado: (2009)

Early and late effects of pharmacological ALK inhibition on the neuroblastoma transcriptome
por: Claeys, Shana, et al.
Publicado: (2017)

External oligonucleotide standards enable cross laboratory comparison and exchange of real-time quantitative PCR data
por: Vermeulen, Joëlle, et al.
Publicado: (2009)

Measurable impact of RNA quality on gene expression results from quantitative PCR
por: Vermeulen, Joëlle, et al.
Publicado: (2011)

Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples
por: Van Goethem, Alan, et al.
Publicado: (2016)

Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions
por: De Preter, Katleen, et al.
Publicado: (2008)

The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
por: Van Roy, Nadine, et al.
Publicado: (2009)

Cancer Gene Prioritization for Targeted Resequencing Using FitSNP Scores
por: Fieuw, Annelies, et al.
Publicado: (2012)

From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma
por: Decaesteker, Bieke, et al.
Publicado: (2021)

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
por: Decaesteker, Bieke, et al.
Publicado: (2018)

Positional and functional mapping of a neuroblastoma differentiation gene on chromosome 11
por: De Preter, Katleen, et al.
Publicado: (2005)

SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
por: Decaesteker, Bieke, et al.
Publicado: (2023)

Correction: Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
por: De Preter, Katleen, et al.
Publicado: (2007)

Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
por: De Preter, Katleen, et al.
Publicado: (2006)

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation
por: Van Goethem, Alan, et al.
Publicado: (2023)

Vehicle development, pharmacokinetics and toxicity of the anti-invasive agent 4-fluoro-3’,4’,5’-trimethoxychalcone in rodents
por: Mus, Liselot M., et al.
Publicado: (2018)

The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
por: Mus, Liselot M., et al.
Publicado: (2020)

RTPrimerDB: the portal for real-time PCR primers and probes
por: Lefever, Steve, et al.
Publicado: (2009)

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
por: Vandesompele, Jo, et al.
Publicado: (2002)

Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma
por: Rihani, Ali, et al.
Publicado: (2015)

Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
por: Afanasyeva, Elena A, et al.
Publicado: (2021)

MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation
por: Beckers, Anneleen, et al.
Publicado: (2014)

The mutational landscape of MYCN, Lin28b and ALK(F1174L) driven murine neuroblastoma mimics human disease
por: De Wilde, Bram, et al.
Publicado: (2017)

A high-throughput 3’ UTR reporter screening identifies microRNA interactomes of cancer genes
por: Van Peer, Gert, et al.
Publicado: (2018)

Genome-wide study of the effect of blood collection tubes on the cell-free DNA methylome
por: Van Paemel, Ruben, et al.
Publicado: (2020)

Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons
por: De Preter, Katleen, et al.
Publicado: (2004)

Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma
por: Kumps, Candy, et al.
Publicado: (2010)

Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes
por: Kumps, Candy, et al.
Publicado: (2013)

CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23
por: Michels, Evi, et al.
Publicado: (2008)

Comprehensive RNA dataset of tissue and plasma from patients with esophageal cancer or precursor lesions
por: Schoofs, Kathleen, et al.
Publicado: (2022)

Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma
por: Cazes, Alex, et al.
Publicado: (2014)

decodeRNA— predicting non-coding RNA functions using guilt-by-association
por: Lefever, Steve, et al.
Publicado: (2017)

Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR
por: Mestdagh, Pieter, et al.
Publicado: (2016)

Custom long non-coding RNA capture enhances detection sensitivity in different human sample types
por: Morlion, Annelien, et al.
Publicado: (2021)

Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma
por: Van Goethem, Alan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ce2gfc8kpggdk2n1gba7h40dq7